O
RPTP

OppenheimerFunds’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

OppenheimerFunds’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-61,085
Closed -$548K – 1862
2016
Q3 		$548K Buy
+61,085
New +$434K ﹤0.01% 1225

OppenheimerFunds's RPTP Position: Q4 2016 in Review

OppenheimerFunds sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 61,085 shares — an estimated $548K sold.

OppenheimerFunds first reported a position in RPTP in Q3 2016 and held it in 1 quarter. The position peaked at $548K in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • OppenheimerFunds reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • OppenheimerFunds sold 61,085 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $548K.
  • OppenheimerFunds first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2016 and held it in 1 quarter.
  • OppenheimerFunds's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $548K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on OppenheimerFunds's 13F filing for Q4 2016, filed 14 Feb 2017.